67 related articles for article (PubMed ID: 30737623)
1. MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial-mesenchymal transition in lung adenocarcinoma.
Xia X; Ge Y; Ge F; Gu P; Liu Y; Li P; Xu P
J Cancer Res Clin Oncol; 2024 Feb; 150(2):88. PubMed ID: 38341398
[TBL] [Abstract][Full Text] [Related]
2. AQP3 Promotes the Invasion and Metastasis in Cervical Cancer by Regulating NOX4-derived H
Wang Q; Lin B; Wei H; Wang X; Nie X; Shi Y
J Cancer; 2024; 15(4):1124-1137. PubMed ID: 38230207
[TBL] [Abstract][Full Text] [Related]
3. High BMP7 expression is associated with poor prognosis in ovarian cancer.
Vasan R; Yadav J; Aiyappa-Maudsley R; Deen S; Storr SJ; Martin SG
J Cell Mol Med; 2023 Nov; 27(21):3378-3387. PubMed ID: 37688374
[TBL] [Abstract][Full Text] [Related]
4. Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme.
Yin J; Liu JS; Feng M; Li JM; Lu S; Yang M; Cao BR; Lang JY; Zhu XD
Transl Cancer Res; 2020 Oct; 9(10):6487-6504. PubMed ID: 35117257
[TBL] [Abstract][Full Text] [Related]
5. CIRCNV: Detection of CNVs Based on a Circular Profile of Read Depth from Sequencing Data.
Zhao HY; Li Q; Tian Y; Chen YH; Alvi HAK; Yuan XG
Biology (Basel); 2021 Jun; 10(7):. PubMed ID: 34202028
[TBL] [Abstract][Full Text] [Related]
6. Dopamine and cAMP-regulated phosphoprotein 32kDa (DARPP-32), protein phosphatase-1 and cyclin-dependent kinase 5 expression in ovarian cancer.
Martin SG; Zhang S; Yang S; Saidy B; Deen S; Storr SJ
J Cell Mol Med; 2020 Aug; 24(16):9165-9175. PubMed ID: 32588513
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin System Protein Expression Is Associated with Poor Clinical Outcome in Adult and Paediatric Gliomas and Medulloblastomas.
Yao A; Storr SJ; Al-Hadyan K; Rahman R; Smith S; Grundy R; Paine S; Martin SG
Mol Neurobiol; 2020 Jul; 57(7):2889-2901. PubMed ID: 32418115
[TBL] [Abstract][Full Text] [Related]
8. MAP4 as a New Candidate in Cardiovascular Disease.
Li L; Zhang Q; Lei X; Huang Y; Hu J
Front Physiol; 2020; 11():1044. PubMed ID: 32982783
[TBL] [Abstract][Full Text] [Related]
9. Expression of Syk and MAP4 proteins in ovarian cancer.
Zhang S; Deen S; Storr SJ; Yao A; Martin SG
J Cancer Res Clin Oncol; 2019 Apr; 145(4):909-919. PubMed ID: 30737623
[TBL] [Abstract][Full Text] [Related]
10. Calpain system protein expression and activity in ovarian cancer.
Zhang S; Deen S; Storr SJ; Chondrou PS; Nicholls H; Yao A; Rungsakaolert P; Martin SG
J Cancer Res Clin Oncol; 2019 Feb; 145(2):345-361. PubMed ID: 30448882
[TBL] [Abstract][Full Text] [Related]
11. Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer.
Storr SJ; Safuan S; Woolston CM; Abdel-Fatah T; Deen S; Chan SY; Martin SG
J Cell Mol Med; 2012 Oct; 16(10):2422-8. PubMed ID: 22435971
[TBL] [Abstract][Full Text] [Related]
12. The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy.
Storr SJ; Zhang S; Perren T; Lansdown M; Fatayer H; Sharma N; Gahlaut R; Shaaban A; Martin SG
Oncotarget; 2016 Jul; 7(30):47927-47937. PubMed ID: 27323818
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules.
Yu Y; Gaillard S; Phillip JM; Huang TC; Pinto SM; Tessarollo NG; Zhang Z; Pandey A; Wirtz D; Ayhan A; Davidson B; Wang TL; Shih IeM
Cancer Cell; 2015 Jul; 28(1):82-96. PubMed ID: 26096845
[TBL] [Abstract][Full Text] [Related]
14. Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in ovarian cancer.
Salehin D; Fromberg I; Haugk C; Dohmen B; Georg T; Bohle RM; Bauerschlag D; Thill M; Friedrich M
Eur J Gynaecol Oncol; 2011; 32(6):628-35. PubMed ID: 22335024
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
